Office of the Director, National Institutes of Health; Notice of Meeting, 28442-28443 [2011-12046]

Download as PDF Emcdonald on DSK2BSOYB1PROD with NOTICES 28442 Federal Register / Vol. 76, No. 95 / Tuesday, May 17, 2011 / Notices Date: June 28, 2011. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: James P. Harwood, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5168, MSC 7840, Bethesda, MD 20892, 301–435– 1256, harwoodj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Vision, Cognition and Pain. Date: June 29–30, 2011. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Michael Selmanoff, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3134, MSC 7844, Bethesda, MD 20892, 301–435– 1119, mselmanoff@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Cell, Molecular, and Computational Biology. Date: June 29–30, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Maria DeBernardi, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6158, MSC 7892, Bethesda, MD 20892, 301–435– 1355, debernardima@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Cognition and Central Visual Processing. Date: June 29–30, 2011. Time: 8 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Edwin C Clayton, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5180, MSC 7844, Bethesda, MD 20892, 301–408– 9041, claytone@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA Panel: Career Development in International Settings. Date: June 29, 2011. Time: 12 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Hilary D Sigmon, PhD, Scientific Review Officer, Center for VerDate Mar<15>2010 16:21 May 16, 2011 Jkt 223001 Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5216, MSC 7852, Bethesda, MD 20892, (301) 594– 6377, sigmonh@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Visual Systems. Date: June 30–July 1, 2011. Time: 8 a.m. to 11 a.m. Agenda: To review and evaluate grant applications. Place: The Ritz-Carlton, Washington, DC, 1150 22nd Street, NW., Washington, DC 20037. Contact Person: George Ann McKie, DVM, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5192, MSC 7846, Bethesda, MD 20892, 301–996– 0993, mckiegeo@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Cancer Diagnostics and Treatments (CDT) SBIR/ STTR. Date: June 30–July 1, 2011. Time: 10 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Syed M Quadri, PhD, Chief, OTC IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6210, MSC 7804, Bethesda, MD 20892, 301–435–1211, quadris@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: May 11, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–12049 Filed 5–16–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Recombinant DNA Advisory Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Recombinant DNA Advisory Committee. PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 Date: June 7–9, 2011. Time: June 7, 2011, 11 a.m. to 5:45 p.m. Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will review and discuss selected human gene transfer protocols, and discuss related data management activities as well as a review of biocontainment for experiments with a defective Lassa virus. Please check the meeting agenda at https://oba.od.nih.gov/ rdna_rac/rac_meetings.html for more information. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Time: June 8, 2011, 8 a.m. to 5:35 p.m. Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will review and discuss selected human gene transfer protocols, including a protocol for severe obesity in subjects who either have a mutation in the melanocortin 4 receptor or Prader-Willi syndrome, and discuss related data management activities. Please check the meeting agenda at https://oba.od.nih.gov/ rdna_rac/rac_meetings.html for more information. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Time: June 9, 2011, 8 a.m. to 11:15 a.m. Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will review and discuss selected human gene transfer protocols, and discuss related data management activities including proposed revisions to the NIH Guidelines for Research with Recombinant DNA Molecules for work with partial viral genomes in tissue culture (Section III–E–1). Please check the meeting agenda at https://oba.od.nih.gov/rdna_rac/ rac_meetings.html. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Chezelle George, Office of Biotechnology Activities, Office of Science Policy/OD, National Institutes of Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892, 301–496–9838, georgec@od.nih.gov. Information is also available on the Institute’s/Center’s home page: https:// oba.od.nih.gov/rdna/rdna.html, where an agenda and any additional information for the meeting will be posted when available. OMB’s ‘‘Mandatory Information Requirements for Federal Assistance Program Announcements’’ (45 FR 39592, June 11, 1980) requires a statement concerning the official government programs contained in the Catalog of Federal Domestic Assistance. Normally NIH lists in its announcements the number and title of affected individual programs for the guidance of the public. Because the guidance in this notice covers virtually every NIH and Federal research program in which DNA recombinant molecule techniques could be used, it has been determined not to be cost effective or in the public interest to attempt to list these programs. Such a list would likely require several additional pages. In addition, NIH could not be certain that every Federal program would be included as many Federal agencies, as well as private organizations, both national and international, have elected to follow the NIH Guidelines. In lieu of the individual program listing, NIH invites E:\FR\FM\17MYN1.SGM 17MYN1 Federal Register / Vol. 76, No. 95 / Tuesday, May 17, 2011 / Notices readers to direct questions to the information address above about whether individual programs listed in the Catalog of Federal Domestic Assistance are affected. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) 28443 as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Notice is hereby given of a change in the meeting of the National Center for Research Resources Special Emphasis Panel, June 14, 2011, 8 a.m. to June 15, 2011, 1 p.m., Marriott Courtyard Gaithersburg Washingtonian Center, which was published in the Federal Register on May 3, 2011, 76 FR 85, page 24890. The meeting date of this meeting has been changed to July 12–13, 2011. The meeting is closed to the public. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Ancillary Studies in Immunomodulation Clinical Trials (R01). Date: June 9, 2011. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817. Contact Person: James T. Snyder, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, DHHS/NIH/NIAID, 6700B Rockledge Drive, MSC 7616, Room #3257, Bethesda, MD 20892, 301–435–1614, james.snyder@nih.gov. Name of Committee: Microbiology, Infectious Diseases and AIDS Initial Review Group, Microbiology and Infectious Diseases Research Committee. Date: June 16, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Crowne Plaza Hotel—Silver Spring, 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: Michelle M. Timmerman, PhD, Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, Room 2217, 6700B Rockledge Drive, MSC– 7616, Bethesda, MD 20892–7616, 301–451– 4573, timmermanm@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, R13 Conference Grant Application. Date: June 17, 2011. Time: 10 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: D.G. Patel, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 756, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–7682, pateldg@niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: May 11, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. Dated: May 11, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–12045 Filed 5–16–11; 8:45 am] [FR Doc. 2011–12043 Filed 5–16–11; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Protection and Programs Directorate, DHS. ACTION: Committee Management; Notice of Partially Closed Federal Advisory Committee Meeting. National Institutes of Health National Institutes of Health SUMMARY: National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Dated: May 10, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–12046 Filed 5–16–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Emcdonald on DSK2BSOYB1PROD with NOTICES National Center for Research Resources; Amended Notice of Meeting VerDate Mar<15>2010 16:21 May 16, 2011 Jkt 223001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 Dated: May 11, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–12041 Filed 5–16–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY [Docket No. DHS–2011–0029] President’s National Security Telecommunications Advisory Committee AGENCY: The President’s National Security Telecommunications Advisory Committee (NSTAC) will meet on Thursday, June 2, 2011, in Washington, DC. The meeting will be partially closed to the public. DATES: The NSTAC will meet in open session on Thursday, June 2, 2011, from 2 p.m. to 5 p.m. and in closed session on Thursday, June 2, 2011, from 10 a.m. to 11:30 a.m. ADDRESSES: The public portion of the meeting will be held at the U.S. E:\FR\FM\17MYN1.SGM 17MYN1

Agencies

[Federal Register Volume 76, Number 95 (Tuesday, May 17, 2011)]
[Notices]
[Pages 28442-28443]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-12046]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Recombinant DNA Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Recombinant DNA Advisory Committee.
    Date: June 7-9, 2011.
    Time: June 7, 2011, 11 a.m. to 5:45 p.m.
    Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will 
review and discuss selected human gene transfer protocols, and 
discuss related data management activities as well as a review of 
biocontainment for experiments with a defective Lassa virus. Please 
check the meeting agenda at https://oba.od.nih.gov/rdna_rac/rac_meetings.html for more information.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Time: June 8, 2011, 8 a.m. to 5:35 p.m.
    Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will 
review and discuss selected human gene transfer protocols, including 
a protocol for severe obesity in subjects who either have a mutation 
in the melanocortin 4 receptor or Prader-Willi syndrome, and discuss 
related data management activities. Please check the meeting agenda 
at https://oba.od.nih.gov/rdna_rac/rac_meetings.html for more 
information.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Time: June 9, 2011, 8 a.m. to 11:15 a.m.
    Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will 
review and discuss selected human gene transfer protocols, and 
discuss related data management activities including proposed 
revisions to the NIH Guidelines for Research with Recombinant DNA 
Molecules for work with partial viral genomes in tissue culture 
(Section III-E-1). Please check the meeting agenda at https://oba.od.nih.gov/rdna_rac/rac_meetings.html.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Chezelle George, Office of Biotechnology 
Activities, Office of Science Policy/OD, National Institutes of 
Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892, 301-496-
9838, georgec@od.nih.gov.

    Information is also available on the Institute's/Center's home 
page: https://oba.od.nih.gov/rdna/rdna.html, where an agenda and any 
additional information for the meeting will be posted when 
available.

OMB's ``Mandatory Information Requirements for Federal Assistance 
Program Announcements'' (45 FR 39592, June 11, 1980) requires a 
statement concerning the official government programs contained in 
the Catalog of Federal Domestic Assistance. Normally NIH lists in 
its announcements the number and title of affected individual 
programs for the guidance of the public. Because the guidance in 
this notice covers virtually every NIH and Federal research program 
in which DNA recombinant molecule techniques could be used, it has 
been determined not to be cost effective or in the public interest 
to attempt to list these programs. Such a list would likely require 
several additional pages. In addition, NIH could not be certain that 
every Federal program would be included as many Federal agencies, as 
well as private organizations, both national and international, have 
elected to follow the NIH Guidelines. In lieu of the individual 
program listing, NIH invites

[[Page 28443]]

readers to direct questions to the information address above about 
whether individual programs listed in the Catalog of Federal 
Domestic Assistance are affected.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: May 10, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-12046 Filed 5-16-11; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.